research Clinical Use of 5α-Reductase Inhibitors
Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.
Search
for
Sort by
Research
180-210 / 1000+ results 
research Efficacy and Safety of a Novel Herbal Solution for the Treatment of Androgenetic Alopecia and Comparison with 5% Minoxidil: A Double-Blind, Randomized Controlled Trial Study
Herbal solution improves hair diameter and density more than 5% minoxidil for androgenetic alopecia.
research Microneedling With Platelet-Rich Plasma Versus Microneedling With Topical 5% Minoxidil in Patients With Androgenetic Alopecia: A Comparative Study
Microneedling with either platelet-rich plasma or 5% minoxidil can increase hair growth in people with androgenetic alopecia, but minoxidil might be slightly better.
research Genetic Analysis of 5 Alpha Reductase Type 2 Enzyme in Relation to Oxidative Stress in Cases of Androgenetic Alopecia in a Sample of Egyptian Population
5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.
research Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Healthy Males and Females in an Open Label Pilot Study
Ageratum conyzoides L. extract may effectively and safely treat hair loss.
research Outcome Of Dutasteride 0.5mg In Androgenic Alopecia
Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.
research A Comparative Study of Combined Microneedling Plus Platelet-Rich Plasma Therapy Versus Microneedling Alone in 50 Patients of Androgenic Alopecia
Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.
research Androgenetic Alopecia in the Pediatric Population: A Retrospective Review of 57 Patients
Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.
research Effect of Dutasteride 0.5 mg/day in Men with Androgenetic Alopecia Recalcitrant to Finasteride
Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.
research Efficacy and Safety of Oral Minoxidil 5 mg Daily During 24-Week Treatment in Male Androgenetic Alopecia
Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.
research Randomized Non-Inferiority Study of Oral Minoxidil (1.25 mg/day) vs. 5% Topical Minoxidil in Treating Female Pattern Hair Loss
Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.
research Chronic Telogen Effluvium: A Study of 5 Patients Over 7 Years
Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.
research An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% Versus Minoxidil 5% Solution in Male Androgenetic Alopecia
Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.
research Platelet-Rich Plasma with Low Dose Oral Minoxidil (1.25 mg Versus 2.5 mg) Along with Trichoscopic Pre- and Post-Treatment Evaluation
Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.
research An Open, Randomized, Comparative Study of Oral Finasteride and 5% Topical Minoxidil in Male Androgenetic Alopecia
Oral finasteride works better than topical minoxidil for hair growth, both are safe.
research Severe Androgenetic Alopecia as a Proxy of Metabolic Syndrome in Male Psoriatic Patients Older Than 59 Years
Severe hair loss links to metabolic issues in older men with psoriasis.
research Efficacy and Safety of Topical KX-826 in Male Subjects with Androgenetic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study
KX-826 is safe and effectively increases hair count in men with hair loss.
research Low-Level Light Therapy Versus Topical 5% Minoxidil in the Management of Androgenetic Alopecia in Males: A Randomized Controlled Trial
Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.
research Comparison of Efficacy of Topical 5% Minoxidil Alone Versus Topical 5% Minoxidil With Autologous Platelet-Rich Plasma (PRP) Therapy in Treatment of Androgenetic Alopecia: A Randomized Open Label Study
Adding PRP to minoxidil improves hair growth in male pattern baldness.
research Comparison of Efficacy of Platelet-Rich Plasma Therapy With or Without Topical 5% Minoxidil in Male-Type Baldness: A Randomized, Double-Blind Placebo Control Trial
PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.
research Reliability of the Pattern Hair Loss Classifications: A Comparison of the Basic and Specific and Norwood–Hamilton Classifications
The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.
research The Effectiveness of Adding Low-Level Light Therapy to Minoxidil 5% Solution in the Treatment of Patients with Androgenetic Alopecia
Adding low-level light therapy to minoxidil improves hair growth and patient satisfaction.
research Treatment of Androgenetic Alopecia with 5-Aminolevulinic Acid Photodynamic Therapy: A Randomized, Placebo-Controlled, Split-Scalp Study of Efficacy and Safety
Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.
research An Open Label, Multi-Center Clinical Trial of Topical 5% Minoxidil Solution for the Treatment of Male Androgenetic Alopecia (A Phase IV Study)
research Open Multicenter Clinical Study of 5% Minoxidil Topical Solution in Patients with Androgenetic Alopecia (Phase 4 Clinical Trial) (Joint Study by the Korean Society for Hair Research)
Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.
research Male Androgenetic Alopecia: Population-Based Study in 1,005 Subjects
58% of men aged 30-50 have hair loss, with severity increasing with age.
research Guidelines for Management of Androgenetic Alopecia Based on BASP Classification: The Asian Consensus Committee Guideline
Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.
research Female Pattern Hair Loss
Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.
research Change in Hair Growth-Related Gene Expression Profile in Human Isolated Hair Follicles Induced by 5-Alpha Reductase Inhibitors – Dutasteride and Finasteride – in the Presence of Testosterone
Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.
research Investigator-Blinded, Controlled, and Randomized Comparative Study on 1565 Nm Non-Ablative Fractional Laser Versus 5% Minoxidil for Treatment of Androgenetic Alopecia
The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.